These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37443346)
21. Metastasis of breast cancer to bones alters the tumor immune microenvironment. Chao X; Zhang Y; Zheng C; Huang Q; Lu J; Pulver EM; Houthuijzen J; Hutten S; Luo R; He J; Sun P Eur J Med Res; 2023 Mar; 28(1):119. PubMed ID: 36915210 [TBL] [Abstract][Full Text] [Related]
22. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC. Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913 [TBL] [Abstract][Full Text] [Related]
24. Effector memory cytotoxic CD3 Sun X; Zhai J; Sun B; Parra ER; Jiang M; Ma W; Wang J; Kang AM; Kannan K; Pandurengan R; Zhang S; Solis LM; Haymaker CL; Raso MG; Mendoza Perez J; Sahin AA; Wistuba II; Yam C; Litton JK; Yang F Mod Pathol; 2022 May; 35(5):601-608. PubMed ID: 34839351 [TBL] [Abstract][Full Text] [Related]
25. Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region. Tomioka N; Hatanaka KC; Okuyama D; Watanabe KI; Yamamoto M; Maeda H; Tachikawa H; Kuwahara S; Shimizu A; Suzuki H; Hatanaka Y; Takahashi M Breast Cancer; 2023 May; 30(3):497-505. PubMed ID: 36892732 [TBL] [Abstract][Full Text] [Related]
26. Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer. Jung M; Rose M; Knuechel R; Loeffler C; Muti H; Kather JN; Gaisa NT; BMC Cancer; 2023 Feb; 23(1):113. PubMed ID: 36726072 [TBL] [Abstract][Full Text] [Related]
27. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma. Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334 [TBL] [Abstract][Full Text] [Related]
28. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma. Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY Front Immunol; 2021; 12():705378. PubMed ID: 34526987 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis. Liu W; Chen G; Zhang C; Liao X; Xie J; Liang T; Liao W; Song L; Zhang X Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):25-35. PubMed ID: 34027599 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma. Liu P; Xiao Q; Zhou B; Dai Z; Kang Y World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313 [TBL] [Abstract][Full Text] [Related]
31. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas. Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434 [TBL] [Abstract][Full Text] [Related]
33. Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis. Duchnowska R; Pęksa R; Radecka B; Mandat T; Trojanowski T; Jarosz B; Czartoryska-Arłukowicz B; Olszewski WP; Och W; Kalinka-Warzocha E; Kozłowski W; Kowalczyk A; Loi S; Biernat W; Jassem J; Breast Cancer Res; 2016 Apr; 18(1):43. PubMed ID: 27117582 [TBL] [Abstract][Full Text] [Related]
34. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma. Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987 [TBL] [Abstract][Full Text] [Related]
35. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy. Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236 [TBL] [Abstract][Full Text] [Related]
36. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559 [TBL] [Abstract][Full Text] [Related]
37. Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment. Lippens L; Van Bockstal M; De Jaeghere EA; Tummers P; Makar A; De Geyter S; Van de Vijver K; Hendrix A; Vandecasteele K; Denys H Int J Cancer; 2020 Jul; 147(2):554-564. PubMed ID: 32017078 [TBL] [Abstract][Full Text] [Related]
38. BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial Orchestration. Bady E; Möller K; Mandelkow T; Raedler JB; Yang C; Ebner J; Lurati MCJ; Simon R; Vettorazzi E; Büscheck F; Luebke AM; Dum D; Menz A; Sauter G; Höflmayer D; Weidemann S; Fraune C; Uhlig R; Bernreuther C; Jacobsen F; Clauditz TS; Wilczak W; Burandt E; Steurer S; Minner S; Lennartz M; Blessin NC Mol Cancer Res; 2023 Jun; 21(6):605-613. PubMed ID: 36976297 [TBL] [Abstract][Full Text] [Related]
39. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers. Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263 [TBL] [Abstract][Full Text] [Related]